Mellitus, E. t. D. Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus. Endocrinology Research Centre.
Chicago Style (17th ed.) CitationMellitus, Editorial team Diabetes. Expert Committee on Novel DPP-4 Inhibitor TRADJENTA (linagliptin) in Treatment of Type 2 Diabetes Mellitus. Endocrinology Research Centre.
MLA (9th ed.) CitationMellitus, Editorial team Diabetes. Expert Committee on Novel DPP-4 Inhibitor TRADJENTA (linagliptin) in Treatment of Type 2 Diabetes Mellitus. Endocrinology Research Centre.
Warning: These citations may not always be 100% accurate.